Skip to content

Ironwood Pharmaceuticals IRWD Collaborative Arrangements — Contract With Customer Liability Current

Similar metrics at other companies

CLB
CLBContract With Customer Liability Current Including Contract With Customer Liability Noncurrent Current Portion
$4.71M-51.8%
Nuvation Bio logo
NUVBContract With Customer Liabilities Current
$9.74M
Innovative Solutions & Support logo
ISSCContract With Customer Liability Current Excluding Related Party
$2.22M+203%
PTC Therapeutics logo
PTCTProduct — Deferred Revenue
$0
Priority Technology Holdings logo
PRTHContract With Customer, Liability, Current And Other
$2.73M+8.9%
Tango Therapeutics logo
TNGXCollaboration Revenue — Contract With Customer Liability Revenue Recognized
$0-100%

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's collaborative arrangements — contract with customer liability current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's collaborative arrangements — contract with customer liability current?
Ironwood Pharmaceuticals (IRWD) reported collaborative arrangements — contract with customer liability current of $1.1M in Q4 2025.
What does collaborative arrangements — contract with customer liability current mean?
This represents the portion of deferred revenue or performance obligations from collaborative arrangements expected to be satisfied within one year. It indicates the amount of consideration received from partners for which the company has yet to fulfill its contractual obligations. A high balance may signal future revenue recognition potential, while a declining balance may indicate the fulfillment of near-term milestones.